If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMBR.L Regulatory News (AMBR)

  • There is currently no data for AMBR

Schedule 1 update - Ambrian plc

16 Mar 2015 11:30

RNS Number : 5221H
AIM
16 March 2015
 



 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

 

Ambrian plc ("Ambrian", the "Company" or, together with its subsidiaries, the "Ambrian Group")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

 

6th Floor

62-64 Cornhill

London

EC3V 3NH

 

COUNTRY OF INCORPORATION:

 

England and Wales

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

 

www.ambrian.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Ambrian is a London-based international metal trading business whose activities are focused on the physical trading of LME base metals - principally copper and also lead, zinc and aluminium. These are mainly sourced in China, Africa, Russia and India and sold to customers in Middle East, China and East Asia. The Company currently employs 33 people in London, Shanghai, Taiwan and Singapore.

 

Pursuant to the Acquisition (as defined in the Admission Document), which constitutes a reverse takeover for the purpose of Rule 14 of the AIM Rules for Companies, Ambrian will acquire an interest in Cimentos de Beira Limitada ("CdB"), which is engaged in the development of a clinker grinding and cement packing operation in Beira, Mozambique with an expected installed capacity of 110 tonnes per hour or approximately 800,000 tons per annum.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

 

111,361,208 ordinary shares of £0.10 each of which 4,500,058 will be held in treasury

 

Note: A total of up to 194,142,046 further ordinary shares may be issued on conversion of convertible securities issued to CGM (for distribution by CGM to CGM Shareholders) as consideration for the Acquisition (such terms as defined in the Admission Document).

 

CAPITAL TO BE RAISED ON ADMISSION (IF APPLICABLE) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

 

No capital to be raised on admission.

 

Market capitalisation was £12.25 million as at close of business on 12 March 2015.

 

Assuming all additional ordinary shares referred to above are issued in consideration for the Acquisition, the implied market capitalisation is £33.61 million (based on the Ambrian share price at close of business on 12 March 2015).

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

 

38.69%

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM COMPANY HAS APPLIED OR AGREED TO HAVE ANY OF ITS SECURITIES (INCLUDING ITS AIM SECURITIES) ADMITTED OR TRADED:

 

N/A

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

Existing Directors

Kevin John Lyon

Chairman *

John Michael Coles

Chief Financial Officer

Roger Francis Clegg

Chief Operating Officer

Edward Hammond Rivers Marlow

Non-Executive Director

Nicolas Francois Marie Rouveyre

Non-Executive Director

Proposed Directors

Robert Fredrik Martin Adair

Chairman **

Jean-Pierre Conrad

Chief Executive Officer **

(* Non-Executive Director effective from Completion)

(** Effective from Completion)

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

Significant Shareholders prior to Admission

Name

Number of Shares

% of Issued Share Capital

CGM Schweiz

31,941,354

29.89%

Kestrel Opportunities

14,119,485

13.21%

Charles Davies

13,461,599

12.60%

Ambrian Capital PLC Trustees

6,259,036

5.86%

Church House Investments

5,000,000

4.68%

Fidelity Investments

4,491,423

4.20%

Significant Shareholders following Admission

Name

Number of Shares

% of Issued Share Capital

Kestrel Opportunities

14,119,485

13.21%

Charles Davies

13,461,599

12.60%

CGM Schweiz

9,584,466

8.97%

Cael Engineering Limited

7,925,409

7.42%

Nicolas Rouveyre

7,925,409

7.42%

Ambrian Capital PLC Trustees

6,259,046

5.86%

Jean-Pierre Conrad

5,106,070

4.78%

Church House Investments

5,000,000

4.68%

Fidelity Investments

4,491,423

4.20%

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

 

N/A

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

(ii) 30 June 2014

(iii) 30 June 2015 (annual report for the 12 months ended 31 December 2014)

30 September 2015 (half-yearly report for the 6 months ended 30 June 2015)

30 June 2016 (annual report for the 12 months ended 31 December 2015)

 

EXPECTED ADMISSION DATE:

 

25 March 2015

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Cenkos Securities plc

66 Hanover Street

Edinburgh EH2 1EL

 

NAME AND ADDRESS OF BROKER:

 

Cenkos Securities plc

66 Hanover Street

Edinburgh EH2 1EL

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

www.ambrian.com

 

The Admission Document contains full details about Ambrian plc and its securities.

 

DATE OF NOTIFICATION:

 

16 March 2015

 

NEW/ UPDATE:

 

Update

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIMLLFSIVIIRLIE
Date   Source Headline
7th Sep 20124:02 pmRNSRequisition of general meeting
24th Jul 20122:46 pmRNSTR1 Notification of major interest in shares
24th Jul 201211:33 amRNSTR1 Notification of major interest in shares
23rd Jul 20125:08 pmRNSTR1 Notification of major interest in shares
23rd Jul 201212:45 pmRNSTR1 Notification of major interest in shares
23rd Jul 201212:08 pmRNSTR1 Notification of major interest in shares
18th Jul 20124:14 pmRNSAppointment
6th Jul 20122:41 pmRNSChange of Company Name
29th Jun 20123:50 pmRNSResult of AGM
11th Jun 20127:00 amRNSFinal Results
2nd Apr 20127:00 amRNSCompletion of Sale of Ambrian Partners Limited
8th Feb 20127:00 amRNSTrading Statement
3rd Nov 20119:40 amRNSDisposal of Subsidiary
28th Sep 20117:00 amRNSHalf Yearly Report
1st Sep 20117:00 amRNSDisposal
4th Aug 201111:35 amRNSDirectorate Change
29th Jun 20114:36 pmRNSResult of AGM
29th Jun 201111:08 amRNSTrading Statement
28th Jun 20114:41 pmRNSDirector/PDMR Shareholding
2nd Jun 20111:52 pmRNSAnnual Financial Report
11th Apr 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSDisposal of Subsidiary
5th Apr 20114:04 pmRNSRe Discussions
1st Mar 20117:00 amRNSHolding(s) in Company
1st Feb 20117:00 amRNSTrading Statement
22nd Dec 20104:29 pmRNSDirectorate Change
17th Dec 20109:32 amRNSHolding(s) in Company
7th Dec 20107:00 amRNSTrading Statement
5th Oct 20103:20 pmRNSHolding(s) in Company
27th Sep 20105:12 pmRNSHolding(s) in Company
22nd Sep 20107:00 amRNSHalf Yearly Report
20th Sep 20108:47 amRNSNomad and Broker
18th Aug 20107:00 amRNSAcquisition
10th Aug 20109:36 amRNSHolding(s) in Company
4th Aug 20108:46 amRNSHolding(s) in Company
6th Jul 201012:17 pmRNSPre-Close Trading Statement
21st Jun 20102:30 pmRNSHolding(s) in Company
8th Jun 20103:31 pmRNSResult of AGM
6th Apr 20103:08 pmRNSDirector/PDMR Shareholding
6th Apr 20109:50 amRNSTransaction in Own Shares
26th Mar 201012:28 pmRNSHolding(s) in Company
23rd Mar 20107:00 amRNSFinal Results
5th Mar 201012:35 pmRNSChange of Registered Office
23rd Feb 20107:00 amRNSSecond Interim Dividend
3rd Feb 20107:00 amRNSAmbrian Establishes Private Equity Business
20th Jan 20107:00 amRNSAmbrian Hires Leading Utilities Analyst
13th Jan 20107:00 amRNSTransaction in Own Shares
6th Jan 20107:00 amRNSTransaction in Own Shares
5th Jan 20107:00 amRNSAmbrian Hires Leading Life Sciences Equities Team
23rd Dec 20097:01 amRNSRe. Share Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.